Short answer
AdaptHealth Corp. (AHCO) filed an 8-K current report with the SEC on November 3, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). AdaptHealth reported financial results for the quarter ended September 30, 2026.
AdaptHealth Corp. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- AdaptHealth reported financial results for the quarter ended September 30, 2026
- Press release issued November 3, 2026 contains the substantive quarterly financial details
- Investors should review Exhibit 99.1 for revenue, profitability, guidance and operating updates
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $745.6M, up 10.9%, with organic growth 12.8% across all reportable segments
- Adjusted EBITDA $141.9M, down 2.9%, with margin declining to 19.0% from 21.7%
- $184.8M goodwill impairment drove $168.2M attributable net loss, versus $10.2M income
- Diabetes Health sale for $235.0M cash remains on track for early 2027 after HSR clearance
- 2026 guidance raised for revenue to $2.88B-$2.90B and Adjusted EBITDA to $510M-$525M, while free cash flow fell to $50M-$75M from $80M-$120M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other AdaptHealth Corp. 8-K filings
Get the next AHCO 8-K as it lands
Follow AHCO for push alerts, or ask the research agent what this filing means.